WO2007112676A1 - Protéine hybride de l'hormone parathyroïde humaine 1-34 et vecteurs d'expression correspondants - Google Patents

Protéine hybride de l'hormone parathyroïde humaine 1-34 et vecteurs d'expression correspondants Download PDF

Info

Publication number
WO2007112676A1
WO2007112676A1 PCT/CN2007/001024 CN2007001024W WO2007112676A1 WO 2007112676 A1 WO2007112676 A1 WO 2007112676A1 CN 2007001024 W CN2007001024 W CN 2007001024W WO 2007112676 A1 WO2007112676 A1 WO 2007112676A1
Authority
WO
WIPO (PCT)
Prior art keywords
fusion protein
parathyroid hormone
peptide
recognition site
rhpth
Prior art date
Application number
PCT/CN2007/001024
Other languages
English (en)
Chinese (zh)
Inventor
Renhuai Zhang
Liming Yang
Yong Yang
Sheji Liu
Bilian Huang
Kai He
Delin Liu
Original Assignee
Shenzhen Watsin Genetech Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Watsin Genetech Ltd. filed Critical Shenzhen Watsin Genetech Ltd.
Publication of WO2007112676A1 publication Critical patent/WO2007112676A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0012Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/35Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Cette invention concerne une protéine hybride comprenant une séquence d'acides aminés de thiorédoxine et une hormone parathyroïde 1-34 aval provenant de la thiorédoxine, et des vecteurs d'expression associés. La protéine hybride peut également contenir un peptide de liaison présentant un site de reconnaissance de l'enzyme protéolytique entre la thiorédoxine et l'hormone parathyroïde 1-34. La protéine hybride peut être utile pour produire l'hormone parathyroïde 1-34 humaine.
PCT/CN2007/001024 2006-03-31 2007-03-29 Protéine hybride de l'hormone parathyroïde humaine 1-34 et vecteurs d'expression correspondants WO2007112676A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2006100709954A CN100484958C (zh) 2006-03-31 2006-03-31 含有人甲状旁腺素1-34的融合蛋白及其表达载体
CN200610070995.4 2006-03-31

Publications (1)

Publication Number Publication Date
WO2007112676A1 true WO2007112676A1 (fr) 2007-10-11

Family

ID=37656127

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2007/001024 WO2007112676A1 (fr) 2006-03-31 2007-03-29 Protéine hybride de l'hormone parathyroïde humaine 1-34 et vecteurs d'expression correspondants

Country Status (3)

Country Link
CN (1) CN100484958C (fr)
HK (1) HK1098489A1 (fr)
WO (1) WO2007112676A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151721A1 (fr) 2010-06-04 2011-12-08 Lupin Limited Procédé de production de protéines de fusion à l'aide de la thioredoxine tronquée d'e. coli

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102191303A (zh) * 2010-11-26 2011-09-21 扬子江药业集团北京海燕药业有限公司 基因重组Tα1的表达和制备方法
CN107941983B (zh) * 2018-01-05 2020-05-15 北京博康健基因科技有限公司 一种rhPTH蛋白或rhPTH蛋白制剂的检测方法和纯度的分析方法
CN110938151B (zh) * 2019-12-30 2023-03-17 重庆艾力彼生物科技有限公司 用于表达甲状旁腺素pth的融合蛋白及重组质粒、重组工程菌
CN112646826A (zh) * 2020-12-23 2021-04-13 无锡和邦生物科技有限公司 编码Trx-hPTH(1-34)融合蛋白的基因序列、重组表达质粒、工程菌及应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1343789A (zh) * 2000-09-18 2002-04-10 中山大学 一种高效原核表达载体
CN1417231A (zh) * 2002-11-29 2003-05-14 西南生物工程产业化中试基地有限公司 重组人甲状旁腺激素pth(1-34)的制备方法
CN1424325A (zh) * 2001-12-12 2003-06-18 中国科学院上海生物工程研究中心 重组人甲状旁腺素1-34肽的生产工艺
CN1706947A (zh) * 2004-06-04 2005-12-14 南京大学生物制药工程研究中心 重组人甲状旁腺激素在大肠杆菌中的构建、表达与纯化方法
CN1807456A (zh) * 2005-01-19 2006-07-26 上海赛金生物医药有限公司 重组人甲状旁腺激素pth1-34的制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1343789A (zh) * 2000-09-18 2002-04-10 中山大学 一种高效原核表达载体
CN1424325A (zh) * 2001-12-12 2003-06-18 中国科学院上海生物工程研究中心 重组人甲状旁腺素1-34肽的生产工艺
CN1417231A (zh) * 2002-11-29 2003-05-14 西南生物工程产业化中试基地有限公司 重组人甲状旁腺激素pth(1-34)的制备方法
CN1706947A (zh) * 2004-06-04 2005-12-14 南京大学生物制药工程研究中心 重组人甲状旁腺激素在大肠杆菌中的构建、表达与纯化方法
CN1807456A (zh) * 2005-01-19 2006-07-26 上海赛金生物医药有限公司 重组人甲状旁腺激素pth1-34的制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011151721A1 (fr) 2010-06-04 2011-12-08 Lupin Limited Procédé de production de protéines de fusion à l'aide de la thioredoxine tronquée d'e. coli

Also Published As

Publication number Publication date
HK1098489A1 (en) 2007-07-20
CN100484958C (zh) 2009-05-06
CN1900120A (zh) 2007-01-24

Similar Documents

Publication Publication Date Title
JP3054192B2 (ja) 副甲状腺ホルモンの製造のための組換えdna法
WO2007112677A1 (fr) Procédé de préparation d'hormone parathyroïdienne humaine 1-34
EP0205475B1 (fr) Procedes de production par recombinaison d'inhibiteurs de protease de serine; sequences d'adn utiles a ces procedes
JP4624495B2 (ja) ヒト・インスリンの生成
US20220372074A1 (en) Production and Purification Method for Polypeptide
WO2007112676A1 (fr) Protéine hybride de l'hormone parathyroïde humaine 1-34 et vecteurs d'expression correspondants
WO2010062279A1 (fr) Procédé de production d’insuline humaine recombinante
US7892787B2 (en) Method for production of recombinant growth hormone in form of hybrid protein
WO1999007735A2 (fr) Expression recombinee du peptide c de l'insuline
JP7266325B2 (ja) 蛍光タンパク質フラグメントを含む融合タンパク質およびその用途
Liu et al. Large scale preparation of recombinant human parathyroid hormone 1–84 from Escherichia coli
US9580488B2 (en) Fusion tags and expression vector system for the expression of human parathyroid hormone (rhPTH)
WO2007068053A1 (fr) Production de protéines par voie recombinante
WO1986003779A1 (fr) Vecteur de secretion de polypeptides, micro-organismes transformes par ledit vecteur, et procede de preparation de polypeptides avec lesdits micro-organismes
JPH11508134A (ja) 肥満症蛋白質中間体およびその製法と使用
KR20150009953A (ko) 1→3 해독 프레임 이동의 감소 방법
MX2014010082A (es) Metodo para la reduccion de desplazamientos del marco de lectura 1->2.
CN107217069B (zh) 原核表达载体及rbFGF-2表达方法与工程菌和应用
KR100407792B1 (ko) 인간 글루카곤 유사펩타이드를 융합파트너로 이용한재조합 단백질의 제조방법
KR100202958B1 (ko) 인슐린 융합단백질로부터 인슐린을 생산하는데 있어서 효소적 절단을 가능케하는 인슐린 융합단백질 유전자를 가진 발현벡터 및 이를 이용한 사람 인슐린의 제조방법
JP2574146B2 (ja) ポリペプチド発現ベクタ−、該ベクタ−で形質転換した宿主及び該宿主によるポリペプチドの製造法
CN116217699A (zh) 一种高效表达羊生长激素的方法
CN115073564A (zh) 一种新型冠状病毒的基因工程重组蛋白、重组载体、重组工程菌和疫苗
CN114621963A (zh) 一种猪魏氏梭菌a型的亚单位疫苗及其制备
CN104672334B (zh) 重组长链人胰岛素样生长因子-i的制备方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07720598

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07720598

Country of ref document: EP

Kind code of ref document: A1